Activest Wealth Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5 Hold
2
– – ﹤0.01% 1051
2026
Q2
$5 Hold
2
– – ﹤0.01% 1336
2026
Q1
$4 Hold
2
– – ﹤0.01% 1225
2025
Q4
$4 Hold
2
– – ﹤0.01% 1120
2025
Q3
$6 Hold
2
– – ﹤0.01% 1135
2025
Q2
$6 Hold
2
– – ﹤0.01% 1032
2025
Q1
$6 Hold
2
– – ﹤0.01% 1035
2024
Q4
$7 Hold
2
– – ﹤0.01% 884
2024
Q3
$7 Sell
2
-1
-33% -$4 ﹤0.01% 556
2024
Q2
$13 Buy
+3
New +$14 ﹤0.01% 513

Activest Wealth Management's KPRX Position: Q3 2026 in Review

Activest Wealth Management held its Kiora Pharmaceuticals (KPRX) position steady in Q3 2026 at 2 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Activest Wealth Management first reported a position in KPRX in Q2 2024 and has held it in 10 quarters since. The position peaked at $13 in Q2 2024. 1 fund tracked by Wall St. Rank holds KPRX as of Q3 2026.

  • Activest Wealth Management held 2 shares of Kiora Pharmaceuticals worth $5 as of Q3 2026.
  • Activest Wealth Management left its Kiora Pharmaceuticals share count unchanged in Q3 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #1051 holding.
  • Activest Wealth Management first reported a position in Kiora Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
  • Activest Wealth Management's Kiora Pharmaceuticals position peaked at $13 in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.